IE 11 is a very old Browser and it`s not supported on this site
de en
Interim report as at 30.06.2024
de en
Business reportPerformance / Multi-year comparison
Business Report Performance

Performance/Multi-year comparison

Indexed performance since launch

BB Biotech AG (SIX)-CHF


Rolling performance

SHARE

NAV

NBI TR

30.06.2023 – 30.06.2024

7.2%

10.2%

12.9%

30.06.2022 – 30.06.2023

(27.1%)

(3.5%)

2.8%

30.06.2021 – 30.06.2022

(31.2%)

(32.4%)

(24.3%)

30.06.2020 – 30.06.2021

30.9%

17.0%

17.8%

28.06.2019 – 30.06.2020

11.7%

20.1%

22.3%

Annual performance

SHARE

NAV

NBI TR

2023

(18.1%)

(7.4%)

(4.8%)

2022

(24.3%)

(11.0%)

(9.1%)

2021

8.3%

(11.5%)

3.0%

2020

19.3%

24.3%

15.8%

2019

18.5%

23.4%

23.0%

Cumulated performance

30.06.2024

SHARE

NAV

NBI TR

YTD

(2.0%)

7.3%

11.9%

1 year

7.2%

10.2%

12.9%

3 years

(46.2%)

(28.1%)

(12.1%)

5 years

(21.3%)

1.0%

26.5%

10 years

109%

86.4%

81.6%

since inception 1)

1 839%

2 002%

1 349%

1 09.11.1993

Annualized performance

30.06.2024

SHARE

NAV

NBI TR

1 year

7.2%

10.2%

12.9%

3 years

(18.7%)

(10.4%)

(4.2%)

5 years

(4.7%)

0.2%

4.8%

10 years

7.6%

6.4%

6.1%

since inception 1)

10.2%

10.5%

9.1%

1 09.11.1993

BB BIOTECH AG (XETRA)-EUR


Rolling performance

SHARE

NAV

NBI TR

30.06.2023 – 30.06.2024

8.6%

11.9%

14.5%

30.06.2022 – 30.06.2023

(25.9%)

(1.2%)

5.2%

30.06.2021 – 30.06.2022

(23.9%)

(25.9%)

(17.0%)

30.06.2020 – 30.06.2021

26.5%

13.5%

14.4%

28.06.2019 – 30.06.2020

17.0%

25.3%

27.4%

Annual performance

SHARE

NAV

NBI TR

2023

(15.2%)

(1.3%)

1.3%

2022

(19.0%)

(6.7%)

(4.5%)

2021

13.3%

(7.8%)

7.4%

2020

18.1%

24.8%

16.1%

2019

23.4%

28.1%

27.6%

Cumulated performance

30.06.2024

SHARE

NAV

NBI TR

YTD

(4.6%)

3.5%

7.9%

1 year

8.6%

11.9%

14.5%

3 years

(38.7%)

(18.0%)

0.1%

5 years

(9.3%)

16.5%

45.8%

10 years

162%

135%

129%

since inception 1)

1 641%

1 796%

1 482%

1 10.12.1997

Annualized performance

30.06.2024

SHARE

NAV

NBI TR

1 year

8.6%

11.9%

14.5%

3 years

(15.1%)

(6.4%)

0.0%

5 years

(1.9%)

3.1%

7.8%

10 years

10.1%

8.9%

8.6%

since inception 1)

11.3%

11.7%

10.9%

1 10.12.1997

Multi-year comparison

30.06.2024

2023

2022

2021

2020

Market capitalization at the end of the period (in CHF mn)

2 221.5

2 368.4

3 058.1

4 274.1

4 107.9

highchart-toggle

Net Asset Value at the end of the period (in CHF mn)

2 386.9

2 323.2

2 686.1

3 283.5

3 887.5

highchart-toggle

Number of shares (in mn)

55.4

55.4

55.4

55.4

55.4

highchart-toggle

Trading volume (in CHF mn)

501.6

906.3

1 482.0

2 101.0

2 315.6

highchart-toggle

Profit/(loss) (in CHF mn)

173.4

(206.6)

(357.8)

(404.8)

691.2

highchart-toggle

Closing price at the end of the period in CHF

40.10

42.75

55.20

77.15

74.15

highchart-toggle

Closing price at the end of the period in EUR

41.60

45.50

56.70

74.05

68.00

highchart-toggle

Stock performance (incl. distributions) 1)

(2.0%)

(18.1%)

(24.3%)

8.3%

19.3%

highchart-toggle

High/low share price in CHF

49.35/38.70

60.70/35.60

78.15/51.00

92.20/73.40

74.70/45.44

highchart-toggle

High/low share price in EUR

52.00/40.15

60.50/37.10

75.40/49.60

86.20/67.80

69.00/43.04

highchart-toggle

Premium/(discount) (annual average)

(1.2%)

7.5%

20.5%

19.5%

9.2%

highchart-toggle

Dividend in CHF

N.A.

2.00

2.85

3.85

3.60

highchart-toggle

Degree of investment (quarterly figures)

113.8%

113.7%

112.8%

108.6%

106.8%

highchart-toggle

Total Expense Ratio (TER) p.a. 2)

1.35%

1.34%

1.27%

1.22%

1.25%

highchart-toggle

1All figures in CHF %, total return-methodology

2Based on market capitalization